BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao F, Zhang C, Han W, Gao XJ, Ma J, Hu YW, Gu X, Ding HZ, Zhu LX, Liu Q. p-Akt as a potential poor prognostic factor for gastric cancer: a systematic review and meta-analysis. Oncotarget 2017;8:59878-88. [PMID: 28938690 DOI: 10.18632/oncotarget.17001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang HF, Wu JH, Gai JW, Yang SQ, Ma QT, Ma HS, Feng Q. MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer. Gene 2018;679:314-9. [PMID: 30218751 DOI: 10.1016/j.gene.2018.09.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
2 Soares C, Melo de Lima Morais T, Carlos R, Mariano FV, Altemani A, Freire de Carvalho MG, Corrêa MB, Dias Dos Reis RR, Amorim LS, Paes de Almeida O, Jorge J. Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas. Oncotarget 2018;9:37291-304. [PMID: 30647870 DOI: 10.18632/oncotarget.26458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yao Z, Gao G, Yang J, Long Y, Wang Z, Hu W, Liu Y. Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis. Front Oncol 2020;10:588200. [PMID: 33363017 DOI: 10.3389/fonc.2020.588200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chantarawong W, Kuncharoen N, Tanasupawat S, Chanvorachote P. Lumichrome Inhibits Human Lung Cancer Cell Growth and Induces Apoptosis via a p53-Dependent Mechanism. Nutr Cancer 2019;71:1390-402. [PMID: 31074646 DOI: 10.1080/01635581.2019.1610183] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wan XM, Zhou XL, Du YJ, Shen H, Yang Z, Ding Y. TASP1 Promotes Proliferation and Migration in Gastric Cancer via EMT and AKT/P-AKT Pathway. J Immunol Res 2021;2021:5521325. [PMID: 34012990 DOI: 10.1155/2021/5521325] [Reference Citation Analysis]
6 Popova NV, Jücker M. The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int J Mol Sci 2021;22:1743. [PMID: 33572326 DOI: 10.3390/ijms22041743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Shi A, Wang T, Jia M, Dong L, Shi H. Effects of SDF-1/CXCR7 on the Migration, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells. Front Genet 2021;12:760048. [PMID: 34858476 DOI: 10.3389/fgene.2021.760048] [Reference Citation Analysis]
8 Zhou C, Zhong X, Song Y, Shi J, Wu Z, Guo Z, Sun J, Wang Z. Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence. Front Oncol 2019;9:1321. [PMID: 31850212 DOI: 10.3389/fonc.2019.01321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 El Omari N, Bakha M, Imtara H, Guaouguaoua FE, Balahbib A, Zengin G, Bouyahya A. Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets. Environ Sci Pollut Res Int 2021;28:47869-903. [PMID: 34308524 DOI: 10.1007/s11356-021-15594-8] [Reference Citation Analysis]
10 Li Z, Zhang Y, Wang R, Zou K, Zou L. Genetic alterations in anaplastic thyroid carcinoma and targeted therapies. Exp Ther Med 2019;18:2369-77. [PMID: 31555347 DOI: 10.3892/etm.2019.7869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
11 Wang Z, Lv J, Li X, Lin Q. The flavonoid Astragalin shows anti-tumor activity and inhibits PI3K/AKT signaling in gastric cancer. Chem Biol Drug Des 2021. [PMID: 34396710 DOI: 10.1111/cbdd.13933] [Reference Citation Analysis]